120 related articles for article (PubMed ID: 28938689)
1. Efficacy and safety of traditional chemotherapies for patients with ovarian neoplasm: a network meta-analysis.
Yang L; Guo G; Sun L; Li C; Zhang H
Oncotarget; 2017 Aug; 8(35):59867-59877. PubMed ID: 28938689
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy among multiple chemotherapeutic interventions combined with radiation therapy for patients with cervix cancer after surgery: A network meta-analysis.
Chang L; Guo R
Oncotarget; 2017 Jul; 8(30):49515-49533. PubMed ID: 28472781
[TBL] [Abstract][Full Text] [Related]
3. Toxicities of different first-line chemotherapy regimens in the treatment of advanced ovarian cancer: A network meta-analysis.
Qu CP; Sun GX; Yang SQ; Tian J; Si JG; Wang YF
Medicine (Baltimore); 2017 Jan; 96(2):e5797. PubMed ID: 28079805
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial.
Pignata S; Scambia G; Ferrandina G; Savarese A; Sorio R; Breda E; Gebbia V; Musso P; Frigerio L; Del Medico P; Lombardi AV; Febbraro A; Scollo P; Ferro A; Tamberi S; Brandes A; Ravaioli A; Valerio MR; Aitini E; Natale D; Scaltriti L; Greggi S; Pisano C; Lorusso D; Salutari V; Legge F; Di Maio M; Morabito A; Gallo C; Perrone F
J Clin Oncol; 2011 Sep; 29(27):3628-35. PubMed ID: 21844495
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Neoadjuvant Treatments for Resectable Gastroesophageal Cancer: A Network Meta-Analysis.
Cai Z; Yin Y; Zhao Z; Xin C; Cai Z; Yin Y; Shen C; Yin X; Wang J; Chen Z; Zhou Y; Zhang B
Front Pharmacol; 2018; 9():872. PubMed ID: 30127746
[No Abstract] [Full Text] [Related]
6. Combinational use of trabectedin and pegylated liposomal doxorubicin for recurrent ovarian cancer: a meta-analysis of phase III randomized controlled trials.
Li C; Qiao S; Kang M; Gao X; Li Z
Am J Transl Res; 2023; 15(12):6675-6689. PubMed ID: 38186978
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.
Mahner S; Meier W; du Bois A; Brown C; Lorusso D; Dell'Anna T; Cretin J; Havsteen H; Bessette P; Zeimet AG; Vergote I; Vasey P; Pujade-Lauraine E; Gladieff L; Ferrero A
Eur J Cancer; 2015 Feb; 51(3):352-8. PubMed ID: 25534295
[TBL] [Abstract][Full Text] [Related]
8. Comparative Efficacy of Therapeutics for Chronic Cancer Pain: A Bayesian Network Meta-Analysis.
Huang R; Jiang L; Cao Y; Liu H; Ping M; Li W; Xu Y; Ning J; Chen Y; Wang X
J Clin Oncol; 2019 Jul; 37(20):1742-1752. PubMed ID: 30939089
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of therapeutic strategies for patients with radiculopathy: A network meta-analysis.
Zhang X; Zhang Z; Wen J; Lu J; Sun Y; Sang D
Mol Pain; 2018; 14():1744806918768972. PubMed ID: 29651898
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive comparison of medication strategies for platinum-sensitive recurrent ovarian cancer: A Bayesian network meta-analysis.
Liu Y; Huang Y; Li J; Wan S; Jiang N; Yang J; Chiampanichayakul S; Tima S; Anuchapreeda S; Wu J
Front Pharmacol; 2022; 13():1010626. PubMed ID: 36438821
[No Abstract] [Full Text] [Related]
11. Comparison of different drug for reducing testosterone levels in women with polycystic ovary syndrome: A systematic review and network meta-analysis.
Hao SL; Zhang CL; Meng XY
Medicine (Baltimore); 2023 Oct; 102(41):e35152. PubMed ID: 37832133
[TBL] [Abstract][Full Text] [Related]
12. Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse.
Pujade-Lauraine E; Wagner U; Aavall-Lundqvist E; Gebski V; Heywood M; Vasey PA; Volgger B; Vergote I; Pignata S; Ferrero A; Sehouli J; Lortholary A; Kristensen G; Jackisch C; Joly F; Brown C; Le Fur N; du Bois A
J Clin Oncol; 2010 Jul; 28(20):3323-9. PubMed ID: 20498395
[TBL] [Abstract][Full Text] [Related]
13. Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis.
Luo XW; Du XQ; Li JL; Liu XP; Meng XY
Cancer Manag Res; 2018; 10():2817-2823. PubMed ID: 30174457
[TBL] [Abstract][Full Text] [Related]
14. A network meta-analysis: the overall and progression-free survival of glioma patients treated by different chemotherapeutic interventions combined with radiation therapy (RT).
Qi L; Ding L; Wang S; Zhong Y; Zhao D; Gao L; Wang W; Lv P; Xu Y; Wang S
Oncotarget; 2016 Oct; 7(42):69002-69013. PubMed ID: 27458167
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: a phase II study.
Power P; Stuart G; Oza A; Provencher D; Bentley JR; Miller WH; Pouliot JF
Gynecol Oncol; 2009 Sep; 114(3):410-4. PubMed ID: 19520420
[TBL] [Abstract][Full Text] [Related]
16. Comparison of PARPis with Angiogenesis Inhibitors and Chemotherapy for Maintenance in Ovarian Cancer: A Network Meta-Analysis.
Feng Y; Huang H; Wan T; Zhang C; Tong C; Liu J
Adv Ther; 2019 Dec; 36(12):3368-3380. PubMed ID: 31599396
[TBL] [Abstract][Full Text] [Related]
17. The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis.
Zhan ZJ; Yao WY; Zhang F; Qiu WZ; Liao K; Feng JH; Tan JY; Liu H; Yuan TZ; Zheng RH; Yuan YW
Front Immunol; 2021; 12():719650. PubMed ID: 34413862
[TBL] [Abstract][Full Text] [Related]
18. A network meta-analysis of eight chemotherapy regimens for treatment of advanced ovarian cancer.
Jiang XP; Rui XH; Guo CX; Huang YQ; Li Q; Xu Y
Oncotarget; 2017 Mar; 8(12):19125-19136. PubMed ID: 27835912
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of targeted therapeutics for patients with radioiodine-refractory differentiated thyroid cancer: Systematic review and network meta-analysis.
Ji X; Liang W; Lv G; Ding C; Lai H; Li L; Zeng Q; Lv B; Sheng L
Front Pharmacol; 2022; 13():933648. PubMed ID: 36091770
[No Abstract] [Full Text] [Related]
20. Acupuncture and moxibustion in patients with cancer-related insomnia: A systematic review and network meta-analysis.
Ou Y; Lin D; Ni X; Li S; Wu K; Yuan L; Rong J; Feng C; Liu J; Yu Y; Wang X; Wang L; Tang Z; Zhao L
Front Psychiatry; 2023; 14():1108686. PubMed ID: 36873228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]